Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


HU10 Mini-Plus - The 10cm wide mini-plus horizontal

Product Description
Scie-Plas™ Green Range™ horizontal gel electrophoresis units offer the ultimate standards in innovative design and manufacture, acquired during our 20-year existence. The Scie-Plas Green Range horizontal gel electrophoresis units currently comprise models with gel tray sizes ranging from 6 x 7.5 to 25 x 30cm. All models incorporate many design and safety features recommended by scientists, either from within our in-house product development team or laboratories worldwide. As a result, all our models are manufactured and finished to the highest specification, easy to use, and, with safety always paramount, CE-marked - conforming to European safety regulations.

The HU10 Mini-Plus horizontal gel unit is ideal for routine preparatory and analytical electrophoresis techniques. It has a maximum 80-sample throughput capacity and features a removable gel-casting tray with end gaskets that allow gels to be cast directly within the tank. The gel-casting tray is simply turned at 90° to the direction of electrophoresis, when the end gaskets form a leak proof seal against the inner walls of the running chamber. Once the gel has set and is ready for loading, the gel-casting tray is then restored to its correct orientation in the direction of electrophoresis.

Alternatively, single gels may be cast outside of the tank using HU10-SCG silicone casting gates or HU10-SS Scie-Plas Super-Seals, while up to 3 additional gels may be cast simultaneously within the HU10-CU mini-gel external casting unit.

FEATURES

Complete System
Mini-plus horizontal gel unit with removable casting tray and 2 x 1mm thick, 16-sample combs and coloured loading strips.
Unit Dimensions (W x L x H): 16.5 x 23 x 6.5cm
Gel Dimensions (W x L): 10 x 11.5cm
Buffer Volume: 450ml
Maximum Sample Capacity: 80
Recommended Power Supplies: Consort EV222
Product HU10 Mini-Plus - The 10cm wide mini-plus horizontal
Company Scie-Plas Ltd
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity 1
Company Logo

Scie-Plas Ltd
22 Cambridge Science Park Milton Road Cambridge CB4 0FJ UK

Tel: +44 (0) 1223 427888
Fax: +44 (0) 1223 420164
Email: Sales@scie-plas.co.uk



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be pair with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!